- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Patent holdings for IPC class A61K 47/26
Total number of patents in this class: 10635
10-year publication summary
|
808
|
833
|
968
|
1031
|
1204
|
1138
|
1112
|
1168
|
1095
|
483
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4643 |
98 |
| Amgen Inc. | 4383 |
83 |
| Azurity Pharmaceuticals, Inc. | 252 |
75 |
| Takeda Pharmaceutical Company Limited | 2718 |
71 |
| Genentech, Inc. | 4090 |
66 |
| Novartis AG | 10338 |
62 |
| Allergan, Inc. | 2198 |
54 |
| Merck Sharp & Dohme LLC | 3737 |
50 |
| Pfizer Inc. | 3375 |
48 |
| Chiesi Farmaceutici S.p.A. | 961 |
47 |
| Daiichi Sankyo Company, Limited | 1890 |
46 |
| Hoffmann-La Roche Inc. | 3726 |
44 |
| Janssen Biotech, Inc. | 1738 |
44 |
| Chugai Seiyaku Kabushiki Kaisha | 1405 |
41 |
| Alkermes Pharma Ireland Limited | 256 |
40 |
| Hanmi Pharm. Co., Ltd. | 597 |
38 |
| Astellas Pharma Inc. | 1035 |
37 |
| F. Hoffmann-La Roche AG | 7847 |
35 |
| Bristol-myers Squibb Company | 4789 |
33 |
| Arecor Limited | 105 |
32 |
| Other owners | 9591 |